DanielRobertKuritzkesMD
Infectious Disease • Boston, MAProfessor of Medicine, Brigham and Women's Hospital
Dr. Kuritzkes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1989 - 1990- Massachusetts General HospitalResidency, Internal Medicine, 1987 - 1989
- Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1986
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MA State Medical License 1984 - 2027
CO State Medical License 1990 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
- Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
- A Comparison of Two Tests for Anti-HIV Drug Resistance
- Join now to see all
Publications & Presentations
PubMed
- Deactivated Cas9-Engineered Magnetic Micromotors toward a Point-of-Care Digital Viral RNA Assay.Younseong Song, Hyunji Park, Prudhvi Thirumalaraju, Niveditha Kovilakath, Joseph Michael Hardie
ACS Nano. 2025-03-11 - Non-canonical HIV drug resistance mutations: need to close existing gaps.Seth Inzaule, Michael R Jordan, Joseph Fokam, Raph L Hamers, Roger Paredes
AIDS. 2025-03-06 - Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir.Richard Taylor Pickering, Archana Asundi, Alex Olson, Katie Soden, Daniel R Kuritzkes
Antiviral Therapy. 2025-02-01
Journal Articles
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical StudiesElizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
- Targeted HIV Testing at Birth Supported by Low and Predictable Mother‐to‐Child Transmission Risk in BotswanaDaniel Kuritzkes, MD, Journal of the International AIDS Society
Authored Content
- Hematopoietic Stem Cell Transplantation for HIV CureJanuary 2016
Press Mentions
This Young Texas Doctor Only Read About Measles. Now She's a Leading Expert Amid OutbreakMarch 6th, 2025- Vitamin a as Measles Treatment? RFK Jr.'S Comments Spark Discussion of Benefits and RisksMarch 6th, 2025
- Is It Too Late to Get a Flu Shot?February 26th, 2025
- Join now to see all
Grant Support
- A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2023–2028
- Boston HIV CTUBRIGHAM AND WOMEN'S HOSPITAL2007–2027
- HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapyBRIGHAM AND WOMEN'S HOSPITAL2021–2026
- Viral Infection and Inflammation Workshop 2024BRIGHAM AND WOMEN'S HOSPITAL2024–2025
- Viral Infection and Inflammation Workshop 2024BRIGHAM AND WOMEN'S HOSPITAL2024–2025
- Viral Infection and Inflammation Workshop 2024BRIGHAM AND WOMEN'S HOSPITAL2024–2025
- A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2018–2025
- Multidisciplinary AIDS Training ProgramBRIGHAM AND WOMEN'S HOSPITAL1990–2025
- Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CtuNational Institute Of Allergy And Infectious Diseases2007–2012
- AIDS Clinical Trials Group NetworkNational Institute Of Allergy And Infectious Diseases2011
- HIV-1 Resistance To Chemokine Receptor AntagonistsNational Institute Of Allergy And Infectious Diseases2007–2011
- AIDS Clinical Trials Group NetworkNational Institute Of Allergy And Infectious Diseases2010
- V3 Loop Characterization By Ultradeep Sequencing During CCR5 Antagonist TherapyNational Institute Of Allergy And Infectious Diseases2009–2010
- HIV-1 Therapeutics And Drug ResistanceNational Center For Research Resources2002–2010
- A Phase IV Study Of Antiretroviral Therapy For Hiv-Infected AdultsNational Center For Research Resources2006
- Fitness Of Enfuvirtide-(T-20)-Resistant HIV-1National Institute Of Allergy And Infectious Diseases2003–2006
- AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2003–2006
- HIV-1 Resistance To Nucleoside AnaloguesNational Institute Of Allergy And Infectious Diseases2002–2004
- Viracept And Sustiva For Treatment Of HIV-1National Center For Research Resources2000–2002
- Phase I Trial Of T-1249 In HIV Infected AdultsNational Center For Research Resources2000–2002
- Actg370 Lamivudine VS Delavirdine In 3TC Experienced SubjectsNational Center For Research Resources1998–2002
- Actg364 Efficacy Of Nelfinavir AND/OR DMP 266 With Nucleoside AnalogsNational Center For Research Resources1998–2002
- HIV-1 Resistance To Nucleoside AnaloguesNational Institute Of Allergy And Infectious Diseases2001
- HIV-1 Therapeutics And Drug ResistanceNational Center For Research Resources2001
- PNU 140690 Dose Escalation--Eval Tolerance Pharmacokinetics Eff In HIVNational Center For Research Resources1999–2000
- HIV-1 Dual Resistance To AZT And 3TCNational Institute Of Allergy And Infectious Diseases1998–2000
- Pharmacokinetics Of Indinavir SulfateNational Center For Research Resources1998–1999
- Hiv-1-Specific Ctls In Perinatally Exposed ChildrenNational Institute Of Allergy And Infectious Diseases1993–1997
- ACTG 251--Thalidomide Treatment For Oral/Esophageal Aphthous UlcersNational Center For Research Resources1996
- ACTG 242--Amytryptilene/Mexiletine For HIV NeuropathyNational Center For Research Resources1996
- Thalidomide Treatment For Oral/Esophageal Aphthous Ulcers + HIV ViremiaNational Center For Research Resources1995
- Evaluation Of Antiviral Effects Of RibozymesNational Institute Of Allergy And Infectious Diseases1994–1995
- HIV Epitopes Recognized By Cytotoxic T LymphocytesNational Institute Of Allergy And Infectious Diseases1990–1993
- Functional Domains Of HTLV Envelope ProteinsNational Center For Research Resources1991
- HIV Epitopes Recognized By Cytotoxic T LymphocytesNational Institute Of Allergy And Infectious Diseases1989–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
